SAS-B approvals dip in 2022 following TGA reforms, but patient numbers still climbing by Martin Lane January 9, 2023April 29, 2024 A total of 118,340 SAS-B approvals were issued by the Therapeutic Goods Administration (TGA) in 2022, […]
MCIA puts industry revenue for H2 FY22 at more than A$100m by Martin Lane December 21, 2022December 22, 2022
Companies urged to ‘tread with care’ as TGA clarifies TGO 93 rules by Martin Lane and Steve Jones December 20, 2022April 29, 2024
Approvals through SAS-B scheme the third highest this year by Steve Jones December 8, 2022April 29, 2024
TGA defends itself as fines backlash gathers pace by Martin Lane and Steve Jones November 24, 2022April 29, 2024
How to interpret the TGA’s Authorised Prescriber figures by Rhys Cohen November 17, 2022April 29, 2024
TGA reminds industry to follow product recall guidelines by Martin Lane November 3, 2022November 3, 2022
TGA issues more heavy fines as advertising crackdown gathers pace by Martin Lane October 31, 2022April 29, 2024
Several cannabis firms under ‘active investigation’ as TGA pledges to maintain tough stance on industry by Steve Jones October 13, 2022April 29, 2024
Industry told to ‘wake up’ as TGA finally bares its teeth in cannabis advertising crackdown by Steve Jones September 29, 2022April 29, 2024
